Case studies
Clarity you can measure.
Real signals from the trialport platform and the trialport Live Network: how people move from discovery to an informed, considered decision, and what that means for the studies and communities they touch.
Numbers can demonstrate what a thousand words can’t.
Better-prepared people, measurably better site outcomes.
Eligibility finds people who can join. Clarity and readiness shape who moves forward and stays the course. The numbers below show what happens when both arrive before screening.
14.3% 79.1%
The share of people who go on to apply for a trial, before and since the launch of readifit.
When people can see how a study fits their health and their life, they are far better able to decide whether the next step is right for them.
Case study · One study, one community
From application to enrollment, with quality holding at every step.
A US pain study saw fast, high-quality flow within weeks of one community going live.
-
31 Applications
Everyone who applied had already worked through a plain-language summary of the study, with medifit and readifit alongside it.
-
61% of applications consent
19 Consented 61%Not 100%, and that is the point. People who realize a trial is not right for them step away before they ever reach a site.
-
73% of those who consented enrol
14 Enrolled to date 73%Everyone who did apply arrived prepared, by choice, and engaged at study level. This led to fewer avoidable screen failures downstream saving time and money.
The self-selection effect
-
91%
Average self-reported likelihood of completing the study
-
94%
Surety of study interest
-
75.3%
of people who complete the medifit + readifit self-reflection tools go on to apply.
Not 100%, and that is the point. People who realize a trial is not right for them step away before they ever reach a site. Everyone who does apply arrives prepared, by choice, and engaged at study level; fewer avoidable screen failures downstream.
The quality of patients coming through has been very strong. We’ve also seen enough interest through trialport that we were able to close enrollment more than three months earlier than planned.
Engagement runs deeper than the peer average.
Average visit duration
Pages per visit
Competitor review, June 2026, across 13 trial-search platforms; third-party metrics are directional.
The cost of deciding late.
80%
of clinical trials miss enrollment timelines. (PMC/JMIR; Tufts CSDD)
~30%
of screened candidates fail on eligibility industry-wide.
$75k–$150k
the cost of a single late-phase dropout.
Under 2 minutes
average visit on trial-finder platforms; the journey ends before the decision. (SimilarWeb, 2026)
Clarity upstream is how these numbers change. Completion ROI is modeled on published benchmarks.
For charities and advocacy communities
Support for your members, on their terms, and proof it works.
A trialport hub lives inside your environment, in your community’s language, with no extraction and no pressure. People explore, understand, and decide for themselves. Here is what that looks like when it goes live.
Case study · Speed and trust
-
30 minutes
to go live inside a patient foundation’s website
-
18 hours
First study application: within 18 hours
Trusted environment
Embedded trialport hub
-
7,500+
searches run through the hub in 2026, from inside the community’s own website
-
80+
patients applied to a study since January 2026. All organic; no campaign, no amplification
-
30 min
to go live inside a patient foundation’s website. First application: within 18 hours
Case study · Every language, no noise
- in 2 weeks, with 0 promotional posts 41 applications
Embedded in a global, multi-language community, trialport delivered translated study pages reaching people in 46 languages. No campaign, no amplification: the hub was simply placed where people already are, and existing interest became action.
Case study · One hub, one quarter
What a single embedded hub generated, before any promotion.
- Searches 1,854
- Trial results viewed 16,391
- Study-page visits 313
- Applications 51
No coordinated social push. No dedicated mailers. Add your community’s support, and the opportunity grows.
886 People
They spent more than five minutes with study information in June alone, alongside 4,763 searches and 127 applications from trusted community spaces. More searches than clicks tells us people are exploring, refining, and looking again. What we measure is not traffic. It is consideration, understanding, and choice.
Case study · Reactivating a stalled study
Eleven months of slow enrollment. Moving again in 48 hours.
A study open for 11 months was onboarded to trialport with outreach into a trusted rare-disease audience. Within 48 hours: 90+ click-throughs and 10 people requesting connection to sites.
10 connected to sites through one outreach effort
6
Chose our partnered study
They saw enough to move forward with confidence. The study matched what they were looking for, and they chose to take the next step.
4
Chose a different study
They found another option that suited them better. That is a good outcome too: the right decision matters more than steering everyone toward the sponsored study.
The promise behind the numbers.
The result isn’t that 6 chose the sponsor’s study. It’s that all 10 got to make a real choice.
trialport does not steer people toward the commercial outcome. It gives them enough information to decide what makes sense for them. Sometimes that is the sponsor’s study. Sometimes it is another study entirely.
That is not leakage. That is the point.
understanding comes first. decisions follow.
What sits behind every number on this page.
Every study on trialport is presented as a plain-language summary with the medifit + readifit self-reflection tools.
medifit™ — “Is this trial right for my health?”
Eligibility criteria translated into plain language, with an individual read on medical fit: where it aligns, where it may not, and what to ask next. Decision support, not a decision; clinical suitability always stays with the investigator and study team.
readifit™ — “Is this trial right for my life?”
A reflection across the parts of life a trial actually touches: understanding, emotional readiness, daily-life fit, support network, coping with uncertainty, and motivation. readifit surfaces readiness; the decision always stays with the person.
The trialport Live Network™
The embedded distribution and engagement layer powered by the platform: grassroots to global charity and advocacy relationships, pathology labs, pharmacy networks, patient research panels, point-of-care access, and trusted media partners. Embedded, trusted, and difficult to replicate.
See how the tools work
Figures accurate as of 31st August 2026.